Mucosal immunogenicity of a recombinant Salmonella typhimurium-cloned heterologous antigen in the absence or presence of coexpressed cholera toxin A2 and B subunits.
about
Effect of attenuated Salmonella enterica serovar Typhimurium expressing a Streptococcus mutans antigen on secondary responses to the cloned proteinAdjuvant activity of a nontoxic mutant of Escherichia coli heat-labile enterotoxin on systemic and mucosal immune responses elicited against a heterologous antigen carried by a live Salmonella enterica serovar Typhimurium vaccine strainEffectiveness of liposomes possessing surface-linked recombinant B subunit of cholera toxin as an oral antigen delivery system.Oral immunization with a Salmonella typhimurium vaccine vector expressing recombinant enterotoxigenic Escherichia coli K99 fimbriae elicits elevated antibody titers for protective immunity.Induction of systemic and mucosal immune responses to human immunodeficiency virus type 1 by a DNA vaccine formulated with QS-21 saponin adjuvant via intramuscular and intranasal routes.Functional and immunogenic characterization of two cloned regions of Streptococcus mutans glucosyltransferase I.Host responses to recombinant hemagglutinin B of Porphyromonas gingivalis in an experimental rat modelNative and mutant forms of cholera toxin and heat-labile enterotoxin effectively enhance protective efficacy of live attenuated and heat-killed Shigella vaccines.Immunogenicity of the B monomer of Escherichia coli heat-labile toxin expressed on the surface of Streptococcus gordonii.Construction and characterization of a Salmonella enterica serovar typhimurium clone expressing a salivary adhesin of Streptococcus mutans under control of the anaerobically inducible nirB promoterMonoclonal antibody-mediated modulation of the humoral immune response against mucosally applied Streptococcus mutans.Mucosal immune responses and protection against tetanus toxin after intranasal immunization with recombinant Lactobacillus plantarum.Induction of protective immunity against Streptococcus mutans colonization after mucosal immunization with attenuated Salmonella enterica serovar typhimurium expressing an S. mutans adhesin under the control of in vivo-inducible nirB promoter.Role of Toll-like receptors in host responses to a virulence antigen of Streptococcus mutans expressed by a recombinant, attenuated Salmonella vector vaccine.Cellular mechanisms of the adjuvant activity of the flagellin component FljB of Salmonella enterica Serovar Typhimurium to potentiate mucosal and systemic responses.Mechanisms of monophosphoryl lipid A augmentation of host responses to recombinant HagB from Porphyromonas gingivalis.Enhanced immunogenicity of a genetic chimeric protein consisting of two virulence antigens of Streptococcus mutans and protection against infection.Contribution of a Streptococcus mutans antigen expressed by a Salmonella vector vaccine in dendritic cell activationCholera toxin B: one subunit with many pharmaceutical applications.Effect of expression level on immune responses to recombinant oral Salmonella enterica serovar Typhimurium vaccines.Role of B7 costimulatory molecules in mediating systemic and mucosal antibody responses to attenuated Salmonella enterica serovar Typhimurium and its cloned antigen.Comparison of intranasal and intramuscular immunization against human immunodeficiency virus type 1 with a DNA-monophosphoryl lipid A adjuvant vaccine.
P2860
Q33551813-6E0E7274-34CE-4024-A832-9E24BFCC880FQ33599389-062234DE-1C9D-4258-9A0C-D647D491C4F1Q33762159-34E48AA8-5A21-425F-8DDC-448321103B01Q33767936-0DEAD9EF-6F6D-4130-9882-C31F6FA80A7BQ33784161-87DA1FE2-AC26-4AAA-8483-35F59EAFF091Q34000356-BF380597-51F6-47DF-87CD-5F66AD95C769Q34001629-89593CF8-1172-4D0E-8B7C-427C702D53DFQ34002438-5602F141-DAA3-47B3-9554-8EA204F93D2CQ34003291-8AB68925-3D03-4798-B743-F7FDDDE7B2A1Q34003662-73B02B7B-15C4-424C-A9F4-D1DD9B14DC5EQ34003768-A182D98D-E099-42F2-9939-8AF5F0A9791DQ34006339-CC836404-2694-4165-8DF2-8328C6AC41D3Q34006720-66240CC6-CAF8-4EBB-84BA-1909F63A7DB0Q34021831-DB4D6BB3-AD57-4959-8636-F4B6AA22170CQ34033524-CD22F272-B23B-4C62-8C4F-2A4B59F6212AQ34126807-B5152314-7076-4C7F-BB57-A6C3A5C51E65Q34259753-EF777BF9-F2D7-45C9-8DE4-C21A93E4D4E3Q35191847-783D879D-3500-4743-8DCF-D98B016DF546Q35232735-B4E7C5A0-A9DF-4DAC-85E4-4A37B0380275Q37224771-7E864726-EC87-4D62-B318-A47FB600B9DDQ37523858-E17048C6-FF80-491C-B7CB-9CB53EE915C0Q39570111-765DD861-BB0A-4C93-898A-7BB3B3E16E1C
P2860
Mucosal immunogenicity of a recombinant Salmonella typhimurium-cloned heterologous antigen in the absence or presence of coexpressed cholera toxin A2 and B subunits.
description
1997 nî lūn-bûn
@nan
1997 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
Mucosal immunogenicity of a re ...... olera toxin A2 and B subunits.
@ast
Mucosal immunogenicity of a re ...... olera toxin A2 and B subunits.
@en
type
label
Mucosal immunogenicity of a re ...... olera toxin A2 and B subunits.
@ast
Mucosal immunogenicity of a re ...... olera toxin A2 and B subunits.
@en
prefLabel
Mucosal immunogenicity of a re ...... olera toxin A2 and B subunits.
@ast
Mucosal immunogenicity of a re ...... olera toxin A2 and B subunits.
@en
P2093
P2860
P1476
Mucosal immunogenicity of a re ...... holera toxin A2 and B subunits
@en
P2093
E Harokopakis
G Hajishengallis
M W Russell
S M Michalek
T E Greenway
P2860
P304
P407
P577
1997-04-01T00:00:00Z